Anebulo Pharmaceuticals, Inc. (ANEB) stock

ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026Score 0/30

$0.00+0.00 (+75.00%)

Close on Oct 19, 2026Market cap $28.76KP/E –Yield –

Anebulo Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Anebulo Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?